In a quest to provide more relevant translational data, traditional in vivo models join forces with new approach methodologies.
Another hallmark of Duke-NUS' graduate-entry model is the breadth of experience its students bring into medicine. In the Class of 2026, that range includes graduates from engineering, product ...
Another hallmark of Duke-NUS' graduate-entry model is the breadth of experience its students bring into medicine. In the ...
PD-(L)1×VEGF bispecifics have emerged as a closely watched new class in immuno-oncology, with multiple candidates advancing ...
SurvivorNet on MSN
A new type of immunotherapy drug showed striking results in hard-to-treat lung cancer, but more data is needed for US patients
A large clinical trial in China (HARMONi-6) found that a new immunotherapy drug, ivonescimab, may help patients with advanced squamous lung cancer stay longer without their disease worsening compared ...
Acurex Biosciences, a biotechnology company developing new medicines for Parkinson’s disease and other neurological disorders, today announced it has been awarded a grant from Aligning Science Across ...
The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2026. If approved, povetacicept will become the first commercialized therapy in Vertex’s emerging ...
(Rubedo), an AI-driven, clinical-stage biotech focused on selective cellular rejuvenation medicines targeting aging cells, today announced preliminary results from a Phase 1b/2a study of RLS-1496 in ...
Harvard’s new grade cap is meant to curb a decade of rising A’s — but confidential course-level data shows the policy will ...
UMSL computer science students in Sharlee Climer’s biological data science course analyze genetic data and network models to ...
Oral and poster presentations span three priority programs in breast, gynecologic, and gastrointestinal cancers, advancing ...
InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results